121 related articles for article (PubMed ID: 35102064)
1. TIMP-1 expression in coronary thrombi associate with myocardial injury in ST-elevation myocardial infarction patients.
Nordeng J; Schandiz H; Solheim S; Åkra S; Hoffman P; Roald B; Bendz B; Arnesen H; Helseth R; Seljeflot I
Coron Artery Dis; 2022 Sep; 33(6):446-455. PubMed ID: 35102064
[TBL] [Abstract][Full Text] [Related]
2. MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy.
Opstad TB; Seljeflot I; Bøhmer E; Arnesen H; Halvorsen S
Cardiology; 2018; 139(1):17-24. PubMed ID: 29141241
[TBL] [Abstract][Full Text] [Related]
3. The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI.
Nordeng J; Schandiz H; Solheim S; Åkra S; Hoffman P; Roald B; Bendz B; Arnesen H; Helseth R; Seljeflot I
Mediators Inflamm; 2021; 2021():5525917. PubMed ID: 34135690
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty.
Kuliczkowski W; Urbaniak J; Hallén J; Woźniak M; Poloński L; Mysiak A; Atar D; Zembala M; Serebruany V
Kardiol Pol; 2013; 71(5):453-63. PubMed ID: 23788085
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of fibrinolytic markers in coronary thrombi.
Nordeng J; Solheim S; Åkra S; Schandiz H; Hoffmann P; Roald B; Bendz B; Arnesen H; Helseth R; Seljeflot I
Thromb J; 2022 Apr; 20(1):23. PubMed ID: 35488283
[TBL] [Abstract][Full Text] [Related]
6. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E
Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201
[TBL] [Abstract][Full Text] [Related]
7. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
[TBL] [Abstract][Full Text] [Related]
8. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
9. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
10. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG
J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
12. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
13. Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction.
Pavkova Goldbergova M; Jarkovsky J; Lipkova J; Littnerova S; Poloczek M; Spinar J; Kubkova L; Kluz K; Kala P; Manousek J; Vasku A; Parenica J
J Appl Genet; 2017 Aug; 58(3):331-341. PubMed ID: 28101856
[TBL] [Abstract][Full Text] [Related]
14. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
[TBL] [Abstract][Full Text] [Related]
15. The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction.
Furenes EB; Opstad TB; Solheim S; Lunde K; Arnesen H; Seljeflot I
Mediators Inflamm; 2014; 2014():385901. PubMed ID: 25294955
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
[TBL] [Abstract][Full Text] [Related]
17. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Tayebjee MH; Lip GY; Blann AD; Macfadyen RJ
Thromb Res; 2005; 115(3):205-10. PubMed ID: 15617743
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.
Lichtinghagen R; Huegel O; Seifert T; Haberkorn CI; Michels D; Flemming P; Bahr M; Boeker KH
Clin Chem; 2000 Feb; 46(2):183-92. PubMed ID: 10657374
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
